Pneumonia, Viral: Multimedia

References

1. Shields AF, Hackman RC, Fife KH, Corey L, Meyers JD. Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med. Feb 28 1985;312(9):529-33. [Medline].

2. Duchin JS, Koster FT, Peters CJ, et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med. Apr 7 1994;330(14):949-55. [Medline].

3. Levy H, Simpson SQ. Hantavirus pulmonary syndrome. Am J Respir Crit Care Med. Jun 1994;149(6):1710-3. [Medline].

4. Sims LD, Domenech J, Benigno C, et al. Origin and evolution of highly pathogenic H5N1 avian influenza in Asia. Vet Rec. Aug 6 2005;157(6):159-64. [Medline].

5. Wong SS, Yuen KY. Avian influenza virus infections in humans. Chest. Jan 2006;129(1):156-68. [Medline].

6. de Jong MD, Hien TT. Avian influenza A (H5N1). J Clin Virol. Jan 2006;35(1):2-13. [Medline].

7. US Department of Health and Human Resources. HHS Declares Public Health Emergency for Swine Flu. Available at http://www.hhs.gov/news/press/2009pres/04/20090426a.html. Accessed April 27, 2009.

8. Centers for Disease Control and Prevention. Swine Influenza (Flu). Available at http://www.cdc.gov/swineflu. Accessed April 27, 2009.

9. World Health Organization. Swine flu illness in the United States and Mexico – update 2. Available at http://www.who.int/en/. Accessed April 27, 2009.

10. Centers for Disease Control and Prevention. Guidance for Clinicians and Public Health Professionals. Available at http://www.cdc.gov/swineflu/guidance. Accessed April 27, 2009.

11. Anderson DJ, Jordan MC. Viral pneumonia in recipients of solid organ transplants. Semin Respir Infect. Mar 1990;5(1):38-49. [Medline].

12. Harrington RD, Hooton TM, Hackman RC, et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis. Jun 1992;165(6):987-93. [Medline].

13. Meyers JD, Flournoy N, Thomas ED. Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. Rev Infect Dis. Nov-Dec 1982;4(6):1119-32. [Medline].

14. Falsey AR, Walsh EE. Viral pneumonia in older adults. Clin Infect Dis. Feb 15 2006;42(4):518-24. [Medline].

15. Falsey AR, McCann RM, Hall WJ, Criddle MM. Evaluation of four methods for the diagnosis of respiratory syncytial virus infection in older adults. J Am Geriatr Soc. Jan 1996;44(1):71-3. [Medline].

16. Osiowy C. Direct detection of respiratory syncytial virus, parainfluenza virus, and adenovirus in clinical respiratory specimens by a multiplex reverse transcription-PCR assay. J Clin Microbiol. Nov 1998;36(11):3149-54. [Medline].

17. Hayden FG, Osterhaus AD, Treanor JJ, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med. Sep 25 1997;337(13):874-80. [Medline].

18. Hayden FG, Treanor JJ, Fritz RS, et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA. Oct 6 1999;282(13):1240-6. [Medline].

19. Hayden FG, Atmar RL, Schilling M, et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med. Oct 28 1999;341(18):1336-43. [Medline].

20. Hirji Z, O'Grady S, Bonham J, et al. Utility of zanamivir for chemoprophylaxis of concomitant influenza A and B in a complex continuing-care population. Can Commun Dis Rep. Feb 1 2001;27(3):21-4. [Medline].

21. Monto AS, Fleming DM, Henry D, et al. Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections. J Infect Dis. Aug 1999;180(2):254-61. [Medline].

22. Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA. Feb 23 2000;283(8):1016-24. [Medline].

23. de Jong MD, Tran TT, Truong HK, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med. Dec 22 2005;353(25):2667-72. [Medline].

24. American Academy of Pediatrics Committee on Infectious Diseases. Use of ribavirin in the treatment of respiratory syncytial virus infection. Pediatrics. Sep 1993;92(3):501-4. [Medline].

25. Davidson RN, Lynn W, Savage P, Wansbrough-Jones MH. Chickenpox pneumonia: experience with antiviral treatment. Thorax. Aug 1988;43(8):627-30. [Medline].

26. Forni AL, Schluger NW, Roberts RB. Severe measles pneumonitis in adults: evaluation of clinical characteristics and therapy with intravenous ribavirin. Clin Infect Dis. Sep 1994;19(3):454-62. [Medline].

27. Wilde JA, McMillan JA, Serwint J, Butta J, O'Riordan MA, Steinhoff MC. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA. Mar 10 1999;281(10):908-13. [Medline].

28. Balfour HH Jr. Antiviral drugs. N Engl J Med. Apr 22 1999;340(16):1255-68. [Medline].

29. Dowell SF, Anderson LJ, Gary HE Jr, et al. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis. Sep 1996;174(3):456-62. [Medline].

30. Feldman S. Varicella-zoster virus pneumonitis. Chest. Jul 1994;106(1 Suppl):22S-27S. [Medline].

31. Feldman S, Stokes DC. Varicella zoster and herpes simplex virus pneumonias. Semin Respir Infect. Jun 1987;2(2):84-94. [Medline].

32. Foy HM, Cooney MK, Allan I, Kenny GE. Rates of pneumonia during influenza epidemics in Seattle, 1964 to 1975. JAMA. Jan 19 1979;241(3):253-8. [Medline].

33. Greenberg SB. Viral pneumonia. Infect Dis Clin North Am. Sep 1991;5(3):603-21. [Medline].

34. Gremillion DH, Crawford GE. Measles pneumonia in young adults. An analysis of 106 cases. Am J Med. Oct 1981;71(4):539-42. [Medline].

35. Heilman CA. From the National Institute of Allergy and Infectious Diseases and the World Health Organization. Respiratory syncytial and parainfluenza viruses. J Infect Dis. Mar 1990;161(3):402-6. [Medline].

36. Hockberger RS, Rothstein RJ. Varicella pneumonia in adults: a spectrum of disease. Ann Emerg Med. Aug 1986;15(8):931-4. [Medline].

37. Hopewell PC, Luce JM. Pulmonary involvement in the acquired immunodeficiency syndrome. Chest. Jan 1985;87(1):104-12. [Medline].

38. Klotman ME, Hamilton JD. Cytomegalovirus pneumonia. Semin Respir Infect. Jun 1987;2(2):95-103. [Medline].

39. Leland DS, Emanuel D. Laboratory diagnosis of viral infections of the lung. Semin Respir Infect. Dec 1995;10(4):189-98. [Medline].

40. Little JW, Hall WJ, Douglas RG Jr, Hyde RW, Speers DM. Amantadine effect on peripheral airways abnormalities in influenza. A study in 15 students with natural influenza A infection. Ann Intern Med. Aug 1976;85(2):177-82. [Medline].

41. Mahmood W, Sacks SL. Anti-infective therapy for viral pneumonia. Semin Respir Infect. Dec 1995;10(4):270-81. [Medline].

42. Pruitt RE, Gremillion DE, Herring RW, et al. Oral asacol in the treatment of mild to moderate ulcerative colitis: the Nashville experience. J Tenn Med Assoc. May 1991;84(5):237. [Medline].

43. Ramsey PG, Fife KH, Hackman RC, Meyers JD, Corey L. Herpes simplex virus pneumonia: clinical, virologic, and pathologic features in 20 patients. Ann Intern Med. Dec 1982;97(6):813-20. [Medline].

44. Shanley JD, Jordan MC. Viral pneumonia in the immunocompromised patient. Semin Respir Infect. Sep 1986;1(3):193-201. [Medline].

45. Sullivan CJ, Jordan MC. Diagnosis of viral pneumonia. Semin Respir Infect. Jun 1988;3(2):148-61. [Medline].

46. Wendt CH, Hertz MI. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host. Semin Respir Infect. Dec 1995;10(4):224-31. [Medline].

47. Wenzel RP, McCormick DP, Beam WE Jr. Parainfluenza pneumonia in adults. JAMA. Jul 17 1972;221(3):294-5. [Medline].

48. Yuen KY, Wong SS. Human infection by avian influenza A H5N1. Hong Kong Med J. Jun 2005;11(3):189-99. [Medline].

49. Zahradnik JM. Adenovirus pneumonia. Semin Respir Infect. Jun 1987;2(2):104-11. [Medline].

Further Reading

Guidelines

• Centers for Disease Control and Prevention - Swine Influenza
• Influenza vaccination of health-care personnel. Recommendations of the Healthcare Infection Control Practices Advisory Committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP).
• Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP).
• Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee.

Clinical trials

• Oseltamivir Randomised Controlled Efficacy Trial
• Zinc as Adjunct to Treatment of Pneumonia

Keywords

viral pneumonia, viral respiratory tract infections, influenza virus, respiratory syncytial virus, RSV, parainfluenza virus, PIV, Orthomyxoviridae, severe acute respiratory syndrome, SARS, avian influenza, swine flu

Contributor Information and Disclosures

Author

Sat Sharma, MD, FRCPC, Professor and Head, Division of Pulmonary Medicine, Department of Internal Medicine, University of Manitoba; Site Director, Respiratory Medicine, St. Boniface General Hospital
Sat Sharma, MD, FRCPC is a member of the following medical societies: American Academy of Sleep Medicine, American College of Chest Physicians, American College of Physicians-American Society of Internal Medicine, American Thoracic Society, Canadian Medical Association, Royal College of Physicians and Surgeons of Canada, Royal Society of Medicine, Society of Critical Care Medicine, and World Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Mark Raymond Wallace, MD, Infectious Disease Fellowship Director, Orlando Regional Healthcare; Clinical Professor of Medicine, Florida State University
Mark Raymond Wallace, MD is a member of the following medical societies: American College of Physicians, American Medical Association, American Society of Tropical Medicine and Hygiene, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

CME Editor

Timothy D Rice, MD, Associate Professor, Departments of Internal Medicine and Pediatrics and Adolescent Medicine, Saint Louis University School of Medicine
Timothy D Rice, MD is a member of the following medical societies: American Academy of Pediatrics and American College of Physicians
Disclosure: Nothing to disclose.

Chief Editor

Zab Mosenifar, MD, Director, Division of Pulmonary and Critical Care Medicine, Director, Women's Guild Pulmonary Disease Institute, Executive Vice Chair, Department of Medicine, Cedars Sinai Medical Center; Professor of Medicine, David Geffen School of Medicine at UCLA
Zab Mosenifar, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, American Federation for Medical Research, and American Thoracic Society
Disclosure: Nothing to disclose.